Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVP in Newly Diagnosed Multiple Myeloma
NCT01376401Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jul 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in multiple myeloma (MM), sponsored by Fundación PETHEMA. Primary endpoint: Response Rate and Complete Response Rate at 1 year. Started Jul 2011; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01376401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376401.